Mass Spec Protein Assays in FFPE Tissue
We are advancing personalized medicine with assays that measure actual proteins in cancer signaling networks in FFPE tissue.
Multiplexed Liquid Tissue®-SRM assays for major cancer signaling networks can advance development of targeted therapies and improve patient stratification. (More...)
Our Liquid Tissue®-SRM molecular pathology tests may improve evaluation of tumors and patient selection for targeted drugs, with EGFR and IGF-1R as the initial focus. (More...)
Our patented Liquid Tissue®-SRM technology platform measures proteins in FFPE tissue. (More...)